Female stress urinary incontinence: office-based urethral bulking agent procedure
Affiliations
- PMID: 21067095
Item in Clipboard
Female stress urinary incontinence: office-based urethral bulking agent procedure
Urol Nurs.
2010 Sep-Oct.
Abstract
Urethral bulking agents have been used extensively to treat women with stress urinary incontinence due to intrinsic sphincter deficiency. This article presents the authors' experience with one of the currently approved urethral bulking agents, Macroplastique, in a urology office setting.
Similar articles
-
Surgery insight: management of failed sling surgery for female stress urinary incontinence.Nat Clin Pract Urol. 2006 Dec;3(12):666-74. doi: 10.1038/ncpuro0657. Nat Clin Pract Urol. 2006. PMID: 17149383 Review.
-
Transurethral implantation of macroplastique for the treatment of female stress urinary incontinence secondary to urethral sphincter deficiency.Eur Urol. 2001 Apr;39(4):383-9. doi: 10.1159/000052474. Eur Urol. 2001. PMID: 11306875 Clinical Trial.
-
Durability of urethral bulking agent injection for female stress urinary incontinence: 2-year multicenter study results.J Urol. 2010 Apr;183(4):1444-9. doi: 10.1016/j.juro.2009.12.038. Epub 2010 Feb 20. J Urol. 2010. PMID: 20171691 Clinical Trial.
-
Stress urinary incontinence.Obstet Gynecol. 2004 Sep;104(3):607-20. doi: 10.1097/01.AOG.0000137874.84862.94. Obstet Gynecol. 2004. PMID: 15339776 Review.
-
Mini-invasive techniques for the treatment of female stress urinary incontinence.Minerva Ginecol. 2007 Dec;59(6):557-69. Minerva Ginecol. 2007. PMID: 18043568 Review.
Cited by
-
Three-dimensional endovaginal ultrasound examination following injection of Macroplastique for stress urinary incontinence: outcomes based on location and periurethral distribution of the bulking agent.Int Urogynecol J. 2013 Jul;24(7):1151-9. doi: 10.1007/s00192-012-1983-9. Epub 2012 Nov 15. Int Urogynecol J. 2013. PMID: 23229417
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical